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Abstract 
The process of autologous cell regeneration (ACR) is a facet of cell therapy and regenerative 
medicine. It is initiated when activated autologous platelet rich plasma alone (PRP), containing 
cytokines or growth factors, is injected into the dermis or other structure in order to initiate a 
regenerative or antiaging process. The recipients resident cells at the target zone are activated by 
biologically active growth factors, derived from the activated platelets in the PRP through a paracrine 
effect. The platelet gel that contains the fibrin and clumped platelets, releases growth factors that 
influences activation of macrophages and stem cells in the recipient site. Tissue regeneration is 
facilitated by stem cell proliferation and differentiation. The PRP that has sealant and wound healing 
properties, may shift the wound healing cascade to the left, thereby speeding up tissue regeneration 
and remodelling by the use of the recipients own plasma. 
Both the fibroblast and myofibroblast play key roles in the wound healing cascade. The fibroblast, of 
mesenchymal origin, plays a pivotal role in the formation of the extracellular matrix and deposition 
of collagen. A failure of organised fibroblast function results in important and disabling disease 
processes and conditions such as chronic ischaemic heart disease and remodelling of the heart, lung 
fibrosis, fibromatosis, solar aged-face, keloids, hypertrophic scar formation, nodular fasciitis, inguinal 
hernia, Dupuytren's disease and scleroderma. More recent additions include frozen shoulder and the 
captured shoulder. In aesthetic medicine, one of the prime functions of fractional photothermolysis 
with lasers, intense pulsed light and radiofrequency devices, is to stimulate dermal fibroblast 
proliferation, by thermal energy thereby increasing collagen deposition which enhances facial 
rejuvenation. Platelet -rich plasma (REGENLAB PRP, REGENLAB-ACR) possesses unique growth factors 
that stimulate, fibroblast, keratinocyte and myoblasts ex vivo in tissue culture, allowing three-
dimensional cell proliferation within the fibrin gel. PRP can be used as a cell carrier (i.e., 
keratinocytes, fibroblasts), may enhance cell retention at the point of treatment. REGENKIT is 
authorized for human use, ISO and CE marked. In this overview fibroblast morphology, tissue culture 
and cell biology relevant to the shoulder surgeon is reviewed. 
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Introduction: Definitions and developmental aspects 
Gray's Anatomy, the definitive work on the structure and function of man, gives a vivid account of 
the connective tissue that is derived from the mesenchyme. [1] Connective tissue consists of cells 
embedded in a matrix or ground substance. [1],[2],[3] The ECM was previously referred to as the 
intercellular substance. [1]  
 
Dorland's Illustrative Medical Dictionary defines a fibroblast as an elongated-shaped connective 
tissue cell with vesicular, oval nucleus and cytoplasmic processes at each end. [4] The cell is of 
mesenchymal or mesoderm origin. A myofibroblast is referred to as an atypical fibroblast displaying 
features of a fibroblast and a smooth muscle cell. Compared to fibroblasts, a myofibroblast has an 
irregular nucleus, abundant RER in the cytocavitary network and numerous collections of 
myofilaments. [4] The term mesoderm refers to cells derived from the epiblast and extraembryonic 
tissues. [5] In Langman's Medical Embryology, the term mesenchyme is used and refers to loosely 
organised embryonic connective tissue regardless of origin. [5] In the embryo, the process of 
gastrulation leads to the development of the three germ layers (ectoderm, mesoderm and 
endoderm) in the third week of gestation. [5] For the purposes of this review then, undifferentiated 
pluripotent mesenchymal cells can give origin to either fibroblasts or lipoblasts. [3] The latter cell line 
develops into uni or multilocular adipocytes. Multilocular (or brown) adipose tissue is comprised of 
numerous lipid droplets and abundant brown mitochondria. [3]  
 
An understanding of the morphology of the fibroblast and myofibroblast is important as these cells 
play an important function in the formation of the ECM and collagen deposition, relevant to wound 
healing [Figure - 1]. Active cellular regeneration (ACR) refers to dermal or tissue 
regeneration/rejuvenation therapy via autologous cell rejuvenation. Central to this theme, is the use 
of PRP which contains important growth factors that favorably impacts on the wound healing 
cascade [Figure - 2]. REGENLAB in Switzerland coined the term REGENACR, thereby implying 
volumetric and cell regeneration, platelet and leukocyte release of growth factors, stem cell 
proliferation and differentiation. The purpose being to facilitate the biological process of tissue 
regeneration and remodelling. For this purpose PRP can be used alone or in combination with cells 
such as keratinocytes, fibroblasts, myoblasts, adipose-derived stem cells, limbal corneal stem cells, 
chondrocytes, pancreas islet cells, stem cells and Schwann cells [Figure - 3]. The platelet/fibrin gel 
then serves as a cell vehicle carrier or biological cell scaffold/construct. This approach via tissue 
engineering is aimed at enhanced cell retention (by enhancing cell embedding) at the recipient site of 
cell therapy. In other words, the donor cells that are engrafted as a platelet gel and cells or with 
nanotechnology for regenerative purposes (i.e. the skin with fibroblasts or myocardium with 
myoblast progenitor cells), will be retained at the recipient tissue bed and prevented from being 
washed away in the lymphatics and venules shortly after injection. The advantage is that autologous 
cell transport medium and cells are utilized and the problems of immunological rejection and 
transmission of disease is obviated. And tissue regeneration is addressed by delivering GF's (from the 
activated platelets) at the recipient site as well as new donor cells (i.e. keratinocytes, myoblasts, 
fibroblasts, fat cells, stem cells and Schwann cells, chondrocytes, islet and beta-cells for diabetes 
mellitus). 
Fibroblasts: Types and functions 
Classically, the fibroblast (denotes an active cell) and fibrocyte (quiescent cell) is described in 
histology textbooks. [3],[6] Basic histology at light microscopic level is reflected in [Table - 1] and 
[Figure - 4]. From a cell biology point of view, fibroblasts grow actively in monolayer culture, while 
fibrocytes show stagnant growth potential [Figure - 5]. This is important as regards the regenerative 
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capacity of the connective tissue. The functions of fibroblasts are well documented and reflected as 
follows. [4],[6]  
 Synthesis of proteins, collagen and elastin (collagen types I, II, III, V, XI). [4]  
 Synthesis of reticular and elastic fibers, glycosaminoglycans, proteoglycans and glycoproteins 
of the extracellular matrix (ECM). 
 Production of growth factors (influence cell growth and differentiation) 
 Transformation into myofibroblasts during wound healing (demonstrates features of both 
fibroblasts and smooth muscle; contain actin microfilaments and myosin; responsible for 
wound contraction during wound healing and closure). The active secretory fibroblast 
cytoplasm is more apparent because of the presence of RER. 
 Production of collagen is reflected in [Table - 2] and pathological conditions related to 
fibroblast dysfunction are reflected in [Table - 3]. 
 Release of serotonin, interleukin and prostaglandins 
 
The cytoplasmic markers of human fibroblasts are as follows: 
 Monoclonal antibody, ER-TR7 (expressed by reticular fibroblasts) 
 Fibroblast- specific protein (FSP-1) 
 5BS antibody (FBS prolyl 4-hydroxylase) 
 Antibodies are available for the identification of collagen, types I, II, III. 
 Antibodies to actin and vimentin are useful for the identification of myofibroblasts 
 
Clinical disorders associated with dysfunctional collagen synthesis and metabolism : After 
Junqueira 
 Ehlers-Danlos type IV (Faulty transcription: inherited defect in procollagen peptides) 
 Ehlers-Danlos type VI (Faulty lysine hydroxylation) 
 Ehlers -Danlos type VII (decreased procollagen peptidase activity) 
 Scurvy (Vitamin C deficiency: cofactor for proline hydroxylase) 
 Ostegenesis imperfecte (gene defect affecting collagen type I) 
 Marfan's syndrome is an autosomal dominant disease in which elastic tissue is weakened. 
Three systems are affected, ocular, skeletal and cardiovascular. Deficiency in the protein 
fibrillin I is responsible for the syndrome. 
Myofibroblasts: Relevance to wound healing orthopaedic surgery and disease 
It is now established that the myofibroblast can be found in normal tissue as well as in a wide variety 
of pathological processes. [7],[8],[9],[10],[11] Myofibroblasts stain positively for alpha-smooth-muscle-actin, 
fibronectin, vimentin and occasionally desmin [Figure - 6]. [9] Disease processes in which 
myofibroblasts feature strongly include, hypertrophic scar, Dupuytren's palmar fibrosis, nodular 
faciitis, the fibromatosis, keloids, postoperative spindle-cell nodule, fibroma of the tendon sheath, 
myofibroblastoma and inflammatory myofibroblastic tumors. [9] Important aspects, regarding 
myofibroblasts need emphasizing and are enumerated below: 
 Cultured myofibroblasts, like dermal fibroblasts can secrete type I and III procollagens into 
culture media. [10]  
 Cultured myofibroblasts as well as dermal fibroblasts can be stained with antibodies directed 
at type I and III procollagens. Therefore, fixed cells can be accurately examined by 
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immunohistochemistry. [10] By electron microscopy, it is possible to demonstrate that 
myofibroblasts portray well-developed dense microfilaments of 40-80 degrees and that are 
prominent in the long axis of the cells. [10] Some researchers view the myofibroblast as a 
modified fibroblast, following differentiation in response to specific signals from the 
extracellular matrix (ECM). [10]  
 Myofibroblasts play an integral part in the wound healing cascade, wound contraction and 
hypertrophic scar formation during the healing of wounds. [11]  
 Myofibroblasts appear in the initial phase of wound healing, generate contractile forces to 
pull both edges of an open wound together and with time undergo apoptosis. [11] If apoptosis 
is disorderly, myofibroblasts have an increased propensity to form wound contracture of the 
hypertrophic scar. [11] Myofibroblasts also play an important role in shoulder adhesive 
capsulitis. Other workers have shown that myofibroblasts play an important role in 
formation of granulation tissue and fibrocontractive diseases. [12] If myofibroblasts become 
overactive and continue, then there is accumulation of excessive amounts of ECM. [12]  
 Myofibroblasts can secrete inflammatory and anti-inflammatory cytokines, growth factors, 
lipid and gaseous inflammatory mediators as well as extracellular matrix proteins and 
proteases. [13] Therefore myofibroblasts play an important role in organogenesis, 
oncogenesis, inflammation, repair and fibrosis in tissues. [13] Workers at the University of 
Texas Medical Branch at Galveston, have shown that transforming growth-factor-beta and 
the PDGF family are key players in the fibrotic response. [13]  
 Lung fibrotic remodelling, as seen in pulmonary fibrosis is a feature of 
fibroblast/myofibroblast activation that results in progressive organ dysfunction, usually with 
a terminal outcome. [14] Possibly, the activation of the myofibroblasts is by a shift in the so 
called T-helper 2 type cytokine network. [14]  
 Granulation tissue fibroblasts and myofibroblasts express alpha-sm actin. Apparently, when 
granulation tissue evolves into a scar, myofibroblasts containing-sm actin disappears due to 
apoptosis. [15] Myofibroblasts develop tensile force through the neoformation of alpha-
smooth muscle actin containing cytoplasmic stress fibers. [16] This generation of wound 
tension has been shown to be a crucial regulator of connective tissue remodelling. [16] Also, 
cell-cell adherens junctions appear to synchronise myofibroblast contractile activity. [16] 
Clearly then, myofibroblasts are necessary for mechanical force development. Researchers 
from Bordeaux, France have shown that fibroblast/myofibroblast transition begins with the 
appearance of the protomyofibroblast, whose stress fibers contain only beta-and-gamma-
cytoplasmic actins. [17] With time, the differentiated myofibroblast displaying stress fibers and 
alpha-smooth muscle actin becomes evident. [17]  
 The unique capabilities of the myofibroblast to induce production of tension in wounds, 
relevant to wound healing and pathological organ remodelling has been established. [18]  
 Histological features of myofibroblasts include a plump-spindle-cell morphology, ill defined 
cytoplasm and less fibrillar than smooth-muscle cells and matrix collagen. [9],[19] A histological 
distinction can be made between smooth muscle and myofibroblastic lesions by studying the 
cell surface that is characterized by prominent fibronectin fibrils and fibronexus junctions. [9]  
 Other researchers, working independently have shown that myfibroblasts can be identified 
in several regions of the body, such as the skin, periodontal ligaments and pulmonary septa. 
Healing of surgical wounds by First intention: Role of the fibroblast locomotion 
The wound healing cascade, consisting of inflammation, granulation tissue, wound contraction, 
collagen accumulation and remodelling is well understood. [19] By day three, collagen is deposited by 
fibroblasts and progresses steadily through the third week. [19] The following factors inhibit wound 
healing: 
 Vitamin C deficiency: inhibition of collagen synthesis and fibroblast proliferation 
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 Glucocorticosteroids: diminished fibrosis 
 Ischemia 
 Nutritional disorders (kwashiorkor and marasmus) 
 Excessive production of collagen (keloids) and granulation tissue (i.e. in burns). Immune and 
autoimmune reactions  
Cell biology: Fibroblast tissue culture, dynamics, biostimulation with Platelet-derived growth 
factors (PRP) and Light-Emitting-Diode (LED) photolight therapy 
 Culture of the skin ex vivo by explant technology is a well-established practice in dermatology. [20] In 
our cell biology facility at Stellenbosch, we have been able to document the following laboratory 
observations regarding dermal fibroblasts culture ex vivo with varying concentrations of platelet-rich 
plasma (REGEN-PRP) and other conventional growth media. Dermal fibroblast outgrowth and 
proliferation is as follows. 
 Human fibroblasts in tissue culture (TC) take about five to seven days to appear from 
explants and cultured at the air-interface ("air-lifting") with or without serum enhanced or 
serum starved media. On fibronectin enriched plates, monolayers are generated but cell 
growth is 2D or planar. 
 Cell yields and proliferation is enhanced by medium enrichment with PRP ex vivo compared 
to controls and serum starved medium. This follows by the stimulation of PDGF, TGF and 
allows cell expansion and proliferation in 3D and monolayers [Figure - 7]. 
 REGEN PRP enhances fibroblast locomotion, spreading by the activation of filapodia and 
lamellipodium. REGENKIT-PRP cell proliferation is greater than other extracts of PRP. Cell 
ruffling is evident. Collagen production is enhanced in vitro by PRP. REGENPRP contains 
quantified potent trophic growth factors such as VEGF, PDGF, IGF and EGF. It is postulated 
that fibroblast proliferation is stimulated by epidermal stem cells cited at the dermal-
epidermal junction. REGENPRP is known to induce chemoattraction of stem cells, neutrophils 
and macrophages, proliferation as well as differentiation. With time, differentiation of stem 
cells occurs, allowing the remodelling of tissues and cells to occur. PDGF is known to be 
operational in the inflammatory phase of the wound healing cascade. In the regeneration 
phase. TGBF, EGF, IGF are also operational but some overlap does occur.  
 Details on the biological activity of PRP are reviewed in the literature. [21],[22],[23],[24] Platelet-
poor plasma (PPP) and platelet rich plasma (PRP) can easily be separated from the plasma in 
a side room or theatre, but very careful centrifugation is indicated. [21],[22],[23] PPP as well as 
PRP have sealant properties and PRP also has important biological wound healing activities. If 
the platelets in a blood clot are activated, by either calcium chloride or thrombin, release of 
important growth factors (GF) occurs. Important GF that impact on the wound healing 
cascade include, PDGF, TGBF alpha and beta, IGF and EGF. [21],[22] The GF's or cytokines 
facilitate the process of wound healing, chemoattraction of fibroblasts and myofibroblasts, 
formation of ECM or scaffold and deposition of GAG and collagen. [21],[22]  
 Of importance is the fact that diploid fibroblasts in cell culture undergo a finite number of 
divisions. [20] At the present time we are not sure if PRP can reverse this important 
phenomenon. Work has been done and it has been demonstrated that senescent dermal 
fibroblasts over express metalloproteinase and theoretically explain age-related atrophy of 
ECM architecture. Because fibroblasts have a restrictive capacity of cell doublings, the cells 
eventually become unresponsive to growth factor stimulation. It is tempting to speculate 
that, PRP could at least ameliorate this restriction in ex vivo culture. 
 Keratinocytes, through release of epidermal cytokines, can modulate their own phenotype, 
through autocrine pathways but also influence dermal fibroblast phenotype by paracrine 
mechanisms. Abnormalities in fibroblast function, such as the disturbed release of IL-6, play a 
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central role in the pathogenesis of scleroderma. TGB-alpha is capable of upregulating type VII 
collagen gene expression in cultured dermal fibroblast and epidermal keratinocytes and this 
is valuable information when evaluating the biostimulatory and physiological effects of PRP. 
 In our light laboratory we have been able to biostimulate and increase proliferation of 
fibroblasts ex vivo by the use of 633nm non-thermal light source (Omnilux™). [25] We can thus 
manipulate and increase cell proliferation by two separate stimulation modalities (non-
thermal light and REGENLAB-PRP which provides 7 secretary proteins, cytokines and growth 
factors), without a noticeable increase in apoptosis. However, the fluency and duration of 
light stimulation has to be adapted for in vitro work and cell proliferation and therefore 
differs from light intensity needed in the clinic for rejuvenation and anti-inflammatory 
purposes. The 633nm light source provides unique features for cell stimulation and has the 
advantage of being athermal and not cell ablative as seen after application of low level laser 
energy stimulation [Figure - 8]. Nominal wave-length of 630-670nm (Omnilux™) can 
selectively stimulate fibroblasts and keratinocytes. However, 830 nm can super-selectively 
stimulate mast cells, neutrophils, macrophages, myofibroblasts and keratinocytes. A 
combination of these two light sources provides stimulation of mast cells, neutrophils, 
macrophages, fibroblasts, myofibroblasts and keratinocytes. LED (red light) is absorbed in the 
mitochondria of cells and leads to ATP stimulation. This may well result in increased cellular 
action potential and enhanced cell vitality. The 633nm light (Omnilux™) emitted is potentially 
absorbed by fibroblasts and this will enhance the speed of neo-collagen synthesis. By 830nm 
stimulation, myofibroblasts are activated and this will improve alignment of newly produced 
collagen bundles. The unique, non-thermal light source, is safe and applicable as an anti-
inflammatory device (i.e. in combination with lasers) and the treatment of acne and skin 
cancers. We provide strong research evidence for the application in facial rejuvenation (i.e. 
for the chronological and photo aged face with wrinkles and skin sagging). [25]  
 
 
We confirm the observations of Albert's et al. , and have observed in our laboratory that fibroblasts 
(of mesenchymal origin and possessing totipotential characteristics) can be stimulated to change 
their character in tissue culture [Figure - 9]. [26] We have observed that human fibroblasts do change 
shape and position in vitro and assume more complex process bearing morphologies when cultured 
in REGEN PRP. [26] We speculate that the growth factors released by activated platelets in PRP, act as 
powerful regulators of growth, differentiation and matrix synthesis of connective tissue cells such as 
fibroblasts. [26] We agree with Albert's et al. that TGBF-beta (released by activated platelets in REGEN 
PRP) is important in wound healing and facilitates conversion of fibroblasts into myofibroblasts and 
thereby promotes the strength of wounds by deposition of collagen-rich scar tissue. [26]  
 
Non-thermal light skin rejuvenation has the advantage over conventional lasers that produce similar 
results but at the cost of longterm scarification of the dermis. At this point in time, it is not known if 
fractional, non-ablative photothermolysis, will also be associated with scarification. Important work 
from the University of Johannesburg, showed that diabetic fibroblast cells at fluencies of 5 and 16 
J/cm 2 , in an experimental model, could favourably enhance cell migration, by the application of 
helium-neon laser irradiation. [27],[28],[29] Also, they showed in this fibroblast model that affluence of 5 
J/cm 2 , stimulated mitochondrial activity and therefore acted as a modifier of cell processes. [27],[28],[29] 
Optimizing correct energy density (fluency) and number of exposures is obviously important to 
ensure efficient fibroblast cell migration and proliferation, both in vivo and in vitro . 
 
Frozen shoulder: Associated with Dupuytren’s disease 
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Although young females between the ages of 40 and 55 years with a frozen shoulder recover almost 
totally, there have been studies showing that some have ongoing discomfort and limitation of 
external rotation. [30],[31],[32],[33] In the orthopedic literature, a reference is made that frozen shoulder is 
an entity presenting with chronic fibrosis of the shoulder joint capsule. [32],[33] Cellular infiltrate has 
been identified to consist of fibroblasts and myofibroblasts. A dense layer of type-III collagen matrix 
is deposited in the shoulder capsule. [30] The collagen undergoes contraction resulting in pain and 
stiffness. The histological picture mimics those found in Dupuytren's disease. [30] Recent literature 
shows that Dupuytren's disease is about 8 times more common in persons with frozen shoulder. [30] 
Indeed, Schaer first noted the association between frozen shoulder and Dupuytren's disease in 1936. 
An association with diabetes mellitus and hyperlipidaemia has also been reported. Other workers 
report, in persons with the frozen shoulder syndrome, cytokine abnormalities and disorder of matrix 
metalloproteinase and metalloproteinase inhibitors. The two conditions seem to have very different 
natural histories. We agree that Dupuytren's disease is a progressive condition and frozen shoulder 
being a self-limiting disorder that fully resolves with time and have little long-term functional 
disability. The results of arthroscopic shoulder rotator cuff repair are excellent, with only a small 
percentage presenting with limited range of motion associated with persistent pain. This 
postoperative scenario of the "captured shoulder" is apparently caused by restrictive sub-deltoid 
adhesions and an associated an articular companion lesion, which no doubt is due to fibroblast 
stimulation and enhanced collagen deposition. [31] These restrictive bands can be lysed at surgery but 
care is needed to avoid injuring the axillary nerve. In all these cases exclusion of unrecognized 
acromioclavicular disease and adhesive capsulitis is needed. Apparently, these patients benefit from 
re-intervention surgery and release of these adhesions results in decreased pain, increase in range of 
movement and return to near normal activities. Focused surgery in selected patients presenting with 
protracted symptoms of idiopathic adhesive capsulitis show deposition of scar tissue in the shoulder 
joint capsule. In addition there is thickening of the coracohumeral ligament. [30],[31],[32],[33] Arthroscopic 
surgical release of the coracohumeral ligament and rotator interval can restore passive external 
rotation and relieves pain [Figure - 10] A and B. 
Rotator cuff repair and PRP augmentation 
Although young females between the ages of 40 and 55 years with a frozen shoulder recover almost 
totally, there have been studies showing that some have ongoing discomfort and limitation of 
external rotation. [30],[31],[32],[33] In the orthopedic literature, a reference is made that frozen shoulder is 
an entity presenting with chronic fibrosis of the shoulder joint capsule. [32],[33] Cellular infiltrate has 
been identified to consist of fibroblasts and myofibroblasts. A dense layer of type-III collagen matrix 
is deposited in the shoulder capsule. [30] The collagen undergoes contraction resulting in pain and 
stiffness. The histological picture mimics those found in Dupuytren's disease. [30] Recent literature 
shows that Dupuytren's disease is about 8 times more common in persons with frozen shoulder. [30] 
Indeed, Schaer first noted the association between frozen shoulder and Dupuytren's disease in 1936. 
An association with diabetes mellitus and hyperlipidaemia has also been reported. Other workers 
report, in persons with the frozen shoulder syndrome, cytokine abnormalities and disorder of matrix 
metalloproteinase and metalloproteinase inhibitors. The two conditions seem to have very different 
natural histories. We agree that Dupuytren's disease is a progressive condition and frozen shoulder 
being a self-limiting disorder that fully resolves with time and have little long-term functional 
disability. The results of arthroscopic shoulder rotator cuff repair are excellent, with only a small 
percentage presenting with limited range of motion associated with persistent pain. This 
postoperative scenario of the "captured shoulder" is apparently caused by restrictive sub-deltoid 
adhesions and an associated an articular companion lesion, which no doubt is due to fibroblast 
stimulation and enhanced collagen deposition. [31] These restrictive bands can be lysed at surgery but 
care is needed to avoid injuring the axillary nerve. In all these cases exclusion of unrecognized 
acromioclavicular disease and adhesive capsulitis is needed. Apparently, these patients benefit from 
re-intervention surgery and release of these adhesions results in decreased pain, increase in range of 
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movement and return to near normal activities. Focused surgery in selected patients presenting with 
protracted symptoms of idiopathic adhesive capsulitis show deposition of scar tissue in the shoulder 
joint capsule. In addition there is thickening of the coracohumeral ligament. [30],[31],[32],[33] Arthroscopic 
surgical release of the coracohumeral ligament and rotator interval can restore passive external 
rotation and relieves pain [Figure - 10] A and B. 
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Figures 
 
Figure 1: Morphology of human fi broblast expanded in REGENLABPRP, showing branching and filopodia x5000 
(Olympus® inverted microscope). Other adjacent cells showed features of cell ruffling. Note nucleus, 
lamellopodium and RER 
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Figure 2: PRP is produced by centrifugation of anticoagulated venous blood taken from the medial cubital fore-
arm vein. The centrifuge must be well-balanced and the buffy coat must be clearly visible. This is visible in the 
left tube. This layer contains neutrophils and platelets. Two spins may be necessary to obtain a good result 
 
Figure 3: PRP primed primary cell culture and showing adipose derived-mesenchymal stem cells. Note adjacent 
apoptotic cell 
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Figure 4: Light microscopy showing human fibroblasts in dense connective tissue (H and E, X100) (With kind 
permission of Dr. W Kleintjes) 
 
Figure 5: Monolayers of fibroblasts densely packed in 3D culture and generated by REGEN PRP 
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Figure 6: Tissue culture with PRP enriched medium showing a myofibroblast and adjacent fibroblast. Tissue 
markers for myofibroblasts include actin and vimentin 
 
Figure 7: Fibroblasts in TC showing locomotion and crawling of fibroblasts in PRP enriched medium 
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Figure 8: Stimulation of fibroblasts in tissue culture ex vivo, with red LED (633 nm) 
 
Figure 9: PRP generated 3D scaffold of human fi broblasts that are critical for the formation of the ECM. Note 
branching of the fibroblasts and cell-cell interaction 
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Figure 10A: Arthroscopic visualization of the rotator interval in a “frozen shoulder” Figure 10B: Arthroscopic 
visualization of the sub-deltoid space adhesions in a “captured shoulder” 
  14 
Tables 
 
Table 1: Classic histological features of fi broblasts: After Gray’s anatomy[1,2] 
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Table 2: Molecular process of collagen synthesis by fibroblasts: After Kessel, Junqueira and Carneiro[3] 
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Table 3: Pathological disease processes related to abnormal or dysfunctional fibroblast and myofibroblast 
morphology and growth characteristics 
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